AAAAAA
Results: 1-25/36
Authors:
AVERETTE HE
AUSTIN JM
BORONOW RC
LEWIS JL
MIKUTA JJ
MORROW CP
NELSON JH
UNDERWOOD PB
BERKOWITZ RS
CURRY SL
FREEL JH
HACKER NF
HOMESLEY HD
HOPKINS MP
JANICEK MF
RUTLEDGE FN
SOPER JT
Citation: He. Averette et al., SOCIETY-OF-GYNECOLOGIC-ONCOLOGISTS CLINICAL-PRACTICE GUIDELINES - INTRODUCTORY-REMARKS, Oncology, 12(3), 1998, pp. 445-445
Authors:
AVERETTE HE
AUSTIN JM
BORONOW RC
LEWIS JL
MIKUTA JJ
MORROW CP
NELSON JH
UNDERWOOD PB
BERKOWITZ RS
CURRY SL
FREEL JH
HACKER NF
HOMESLEY HD
HOPKINS MP
JANICEK MF
RUTLEDGE FN
SOPER JT
Citation: He. Averette et al., INTRODUCTORY-REMARKS, Oncology, 12(1), 1998, pp. 119-119
Authors:
LENTZ SS
HOMESLEY HD
Citation: Ss. Lentz et Hd. Homesley, GYNECOLOGIC PROBLEMS IN OLDER WOMEN, Clinics in geriatric medicine, 14(2), 1998, pp. 297
Authors:
ROSE PG
BLESSING JA
MAYER AR
HOMESLEY HD
Citation: Pg. Rose et al., PROLONGED ORAL ETOPOSIDE AS 2ND-LINE THERAPY FOR PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN-CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUPSTUDY, Journal of clinical oncology, 16(2), 1998, pp. 405-410
Authors:
MUGGIA FM
BLESSING JA
HOMESLEY HD
SOROSKY J
Citation: Fm. Muggia et al., TOMUDEX (ZD1694, NSC639186) IN PLATINUM-PRETREATED RECURRENT EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY BY THE GYNECOLOGIC-ONCOLOGY-GROUP, Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 68-70
Authors:
HOMESLEY HD
Citation: Hd. Homesley, SINGLE-AGENT THERAPY FOR NONMETASTATIC AND LOW-RISK GESTATIONAL TROPHOBLASTIC DISEASE, Journal of reproductive medicine, 43(1), 1998, pp. 69-74
Authors:
CREASMAN WT
ZAINO RJ
MAJOR FJ
DISAIA PJ
HATCH KD
HOMESLEY HD
Citation: Wt. Creasman et al., EARLY INVASIVE-CARCINOMA OF THE CERVIX (3 TO 5 MM INVASION) - RISK-FACTORS AND PROGNOSIS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of obstetrics and gynecology, 178(1), 1998, pp. 62-65
Authors:
RANDALL ME
BARRETT RJ
SPIRTOS NM
CHALAS E
HOMESLEY HD
LENTZ SL
HANNA M
Citation: Me. Randall et al., CHEMOTHERAPY, EARLY SURGICAL REASSESSMENT, AND HYPERFRACTIONATED ABDOMINAL RADIOTHERAPY IN STAGE-III OVARIAN-CANCER - RESULTS OF A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, International journal of radiation oncology, biology, physics, 34(1), 1996, pp. 139-147
Authors:
MALFETANO JH
BLESSING JA
HOMESLEY HD
LOOK KY
MCGEHEE R
Citation: Jh. Malfetano et al., A PHASE-II TRIAL OF DIDEMNIN-B (NSC-NUMBER-335319) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX A GYNECOLOGIC-ONCOLOGY-GROUP STUDY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(2), 1996, pp. 184-186
Authors:
REISINGER SA
ASBURY R
LIAO SY
HOMESLEY HD
Citation: Sa. Reisinger et al., A PHASE-I STUDY OF WEEKLY CISPLATIN AND WHOLE ABDOMINAL RADIATION FORTHE TREATMENT OF STAGE-III AND STAGE-IV ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY, Gynecologic oncology, 63(3), 1996, pp. 299-303
Authors:
LOOK KY
BRUNETTO VL
CLARKEPEARSON DL
AVERETTE HE
MAJOR FJ
ALVAREZ RD
HOMESLEY HD
ZAINO RJ
Citation: Ky. Look et al., AN ANALYSIS OF CELL-TYPE IN PATIENTS WITH SURGICALLY STAGED STAGE IB CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 63(3), 1996, pp. 304-311
Authors:
KRIS MG
CUBEDDU LX
GRALLA RJ
CUPISSOL D
TYSON LB
VENKATRAMAN E
HOMESLEY HD
Citation: Mg. Kris et al., ARE MORE ANTIEMETIC TRIALS WITH A PLACEBO NECESSARY - REPORT OF PATIENT DATA FROM RANDOMIZED TRIALS OF PLACEBO ANTIEMETICS WITH CISPLATIN, Cancer, 78(10), 1996, pp. 2193-2198
Authors:
HOMESLEY HD
Citation: Hd. Homesley, SURGICAL STAGING FOR ENDOMETRIAL CANCER - REPLY, American journal of obstetrics and gynecology, 175(2), 1996, pp. 513-514
Authors:
HOMESLEY HD
Citation: Hd. Homesley, MANAGEMENT OF ENDOMETRIAL CANCER, American journal of obstetrics and gynecology, 174(2), 1996, pp. 529-534
Authors:
MCGUIRE WP
HOSKINS WJ
BRADY MF
HOMESLEY HD
CREASMAN WT
BERMAN ML
BALL H
BEREK JS
WOODWARD J
Citation: Wp. Mcguire et al., ASSESSMENT OF DOSE-INTENSIVE THERAPY IN SUBOPTIMALLY DEBULKED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(7), 1995, pp. 1589-1599
Authors:
GANDARA DR
NAHHAS WA
ADELSON MD
LICHTMAN SM
PODCZASKI ES
YANOVICH S
HOMESLEY HD
BRALY P
RITCH PS
WEISBERG SR
WILLIAMS L
DIASIO RB
PEREZ EA
KARP D
REICH SD
MCCARROLL K
HOFF JV
Citation: Dr. Gandara et al., RANDOMIZED PLACEBO-CONTROLLED MULTICENTER EVALUATION OF DIETHYLDITHIOCARBAMATE FOR CHEMOPROTECTION AGAINST CISPLATIN-INDUCED TOXICITIES, Journal of clinical oncology, 13(2), 1995, pp. 490-496
Authors:
MALFETANO JH
BLESSING JA
HOMESLEY HD
Citation: Jh. Malfetano et al., A PHASE-II TRIAL OF GALLIUM NITRATE (NSC NUMBER-15200) IN NONSQUAMOUSCELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(6), 1995, pp. 495-497
Authors:
LENTZ SS
HOMESLEY HD
Citation: Ss. Lentz et Hd. Homesley, RADIATION-INDUCED VESICOSACRAL FISTULA - TREATMENT WITH CONTINENT URINARY-DIVERSION, Gynecologic oncology, 58(2), 1995, pp. 278-280
Authors:
BRALY PS
BEREK JS
BLESSING JA
HOMESLEY HD
AVERETTE H
Citation: Ps. Braly et al., INTRAPERITONEAL ADMINISTRATION OF CISPLATIN AND 5-FLUOROURACIL IN RESIDUAL OVARIAN-CANCER - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP TRIAL, Gynecologic oncology, 56(2), 1995, pp. 164-168
Authors:
HOMESLEY HD
Citation: Hd. Homesley, MANAGEMENT OF VULVAR CANCER, Cancer, 76(10), 1995, pp. 2159-2170
Authors:
HOMESLEY HD
Citation: Hd. Homesley, MANAGEMENT OF VULVAR CANCER, Cancer, 75(10), 1995, pp. 2646-2647
Authors:
HOMESLEY HD
Citation: Hd. Homesley, CARCINOMA OF THE ENDOMETRIUM - ISSUES OF THE 1990S, Seminars in oncology, 21(1), 1994, pp. 63-63
Authors:
HOMESLEY HD
ZAINO R
Citation: Hd. Homesley et R. Zaino, ENDOMETRIAL CANCER - PROGNOSTIC FACTORS, Seminars in oncology, 21(1), 1994, pp. 71-78
Authors:
SUTTON GP
BLESSING JA
HOMESLEY HD
MALFETANO JH
Citation: Gp. Sutton et al., A PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN PATIENTS WITH ADVANCED ORRECURRENT MIXED MESODERMAL TUMORS OF THE OVARY PREVIOUSLY TREATED WITH PLATINUM-BASED CHEMOTHERAPY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 53(1), 1994, pp. 24-26
Authors:
KADAR N
HOMESLEY HD
MALFETANO JH
Citation: N. Kadar et al., PROGNOSTIC FACTORS IN SURGICAL STAGE-III AND STAGE-IV CARCINOMA OF THE ENDOMETRIUM, Obstetrics and gynecology, 84(6), 1994, pp. 983-986